Format

Send to

Choose Destination
Cancer Res. 2015 Mar 15;75(6):1056-67. doi: 10.1158/0008-5472.CAN-14-2249. Epub 2015 Jan 22.

Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.

Author information

1
Department of Biological Sciences, University of Southern California, Los Angeles, California.
2
Longevity Institute, Davis School of Gerontology, University of Southern California, Los Angeles, California.
3
Department of Biological Sciences, University of Southern California, Los Angeles, California. Longevity Institute, Davis School of Gerontology, University of Southern California, Los Angeles, California. IFOM, FIRC Institute of Molecular Oncology, Milano, Italy. vlongo@usc.edu.

Abstract

Short-term starvation or fasting can augment cancer treatment efficacy and can be effective in delaying cancer progression in the absence of chemotherapy, but the underlying molecular mechanisms of action remain elusive. Here, we describe the role of REV1, a specialized DNA polymerase involved in DNA repair, as an important signaling node linking nutrient sensing and metabolic control to cell fate. We show that REV1 is a novel binding partner of the tumor suppressor p53 and regulates its activity. Under starvation, REV1 is modified by SUMO2/3, resulting in the relief of REV1's inhibition of p53 and enhancing p53's effects on proapoptotic gene expression and apoptosis in breast cancer and melanoma cells. Thus, fasting in part through its effect on REV1 is a promising nontoxic strategy to increase p53-dependent cell death and to enhance the efficacy of cancer therapies.

PMID:
25614517
PMCID:
PMC4359966
DOI:
10.1158/0008-5472.CAN-14-2249
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center